Menu
Annual · values202520242023202220212020
Operating Cash Flow-31.06 M USD-44.15 M USD-45.08 M USD-58.55 M USD-54.96 M USD-31.00 M USD
Depreciation & Amortization3.25 M USD3.36 M USD3.10 M USD2.84 M USD1.53 M USD1.51 M USD
Stock-Based Compensation4.03 M USD3.87 M USD4.75 M USD4.02 M USD1.84 M USD533000 USD
Capital Expenditures850000 USD1.36 M USD1.84 M USD6.74 M USD3.22 M USD690000 USD
Cash Flow from Investing14.33 M USD36.66 M USD42.15 M USD-93.47 M USD-13.29 M USD-15.67 M USD
Cash Flow from Financing19.77 M USD203000 USD149000 USD693000 USD216.75 M USD64.23 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-31.91 M USD-45.52 M USD-46.93 M USD-65.29 M USD-58.18 M USD-31.69 M USD

Rapid Micro Biosystems, Inc. is a prominent entity in the life sciences sector, focusing on automation solutions for microbial detection in pharmaceutical manufacturing. The company's primary function is to enhance quality control processes through advanced technologies, enabling quicker and more reliable detection of microbial contamination. Rapid Micro Biosystems operates in an industry that demands stringent safety and regulatory compliance, thus playing a crucial role in ensuring product integrity and patient safety. Its innovative detection systems, designed to meet the needs of biopharmaceutical companies and related industries, underscore significant technological advancements in microbial quality control. As the company continues to evolve within its market, it actively contributes to improving operational efficiency and safeguarding public health through cutting-edge scientific solutions.